[Zirconium hexacyanoferroate in the therapy of intravenous strontium-85 and cesium-134 lesion of the body].
D000818:Animals; D002588:Cesium Radioisotopes / Q000009:adverse effects*; D004353:Drug Evaluation, Preclinical; D005295:Ferrocyanides / Q000627:therapeutic use*; D007275:Injections, Intravenous; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D051381:Rats; D013326:Strontium Radioisotopes / Q000009:adverse effects*; D013997:Time Factors; D015040:Zirconium / Q000627:therapeutic use*
D002588:Cesium Radioisotopes; D005295:Ferrocyanides; D013326:Strontium Radioisotopes; D015040:Zirconium
Geksatsianoferroat tsirkoniia v terapii vnutrennego zarazheniia organizma strontsiem-85 i tseziem-134.